TRAVERE THERAPEUTICS, INC.

TVTX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Profit History

Revenue Operating Income Net Income

Period	Revenue	Operating Income	Net Income
May 2011	$0	$-3.5K	$-3.5K
Aug 2011	$0	$-3.5K	$-3.5K
Nov 2011	$0	$-3.5K	$-3.5K
Mar 2012	—	$-3.6M	$-3.6M
May 2012	$0	$-3.5K	$-3.5K
Jun 2012	—	$-4.7M	$-4.8M
Aug 2012	$0	$-3.5K	$-3.5K
Sep 2012	—	$-8.5M	$-8.5M
Nov 2012	$0	$-3.7K	$-3.7K
Mar 2013	—	$-1.9M	$-4.9M
Jun 2013	—	$-5.0M	$-4.9M
Sep 2013	—	$-6.0M	$-12.0M
Dec 2013	—	$-11.9M	$-12.8M
Mar 2014	$28.0K	$-22.1M	$-75.7M
Jun 2014	$5.7M	$-17.2M	$11.8M
Sep 2014	$8.3M	$-21.9M	$-18.0M
Dec 2014	$14.1M	$-18.7M	$-29.0M
Mar 2015	$17.4M	$-8.1M	$39.7M
Jun 2015	$24.1M	$-6.9M	$-25.5M
Sep 2015	$28.0M	$-20.5M	$105.6M
Dec 2015	$30.4M	$-15.2M	$-2.5M
Mar 2016	$29.0M	$-8.2M	$11.2M
Jun 2016	$33.3M	$-11.4M	$-13.4M
Sep 2016	$33.9M	$-20.4M	$-37.1M
Dec 2016	$37.3M	$-18.2M	$-8.6M
Mar 2017	$33.6M	$-14.4M	$-11.1M
Jun 2017	$38.8M	$-13.6M	$-13.2M
Sep 2017	$40.3M	$-10.6M	$-17.8M
Dec 2017	$42.2M	$-15.2M	$-17.6M
Mar 2018	$38.4M	$-17.9M	$-18.4M
Jun 2018	$41.3M	$-21.6M	$-22.3M
Sep 2018	$40.7M	$-35.6M	$-54.5M
Dec 2018	$43.8M	$-5.0M	$-7.5M
Mar 2019	$39.6M	$-38.2M	$-41.0M
Jun 2019	$44.7M	$-36.5M	$-38.7M
Sep 2019	$44.4M	$-34.4M	$-36.5M
Dec 2019	$46.7M	$-28.2M	$-30.3M
Mar 2020	$47.8M	$-15.1M	$808.0K
Jun 2020	$48.4M	$-23.1M	$-26.1M
Sep 2020	$51.1M	$-19.4M	$-22.5M
Dec 2020	$51.0M	$-118.6M	$-121.6M
Mar 2021	$47.4M	$-47.5M	$-53.9M
Jun 2021	$54.6M	$-35.3M	$-39.0M
Sep 2021	$68.2M	$-31.7M	$-35.6M
Mar 2022	$23.4M	$-72.0M	$-76.0M
Jun 2022	$28.6M	$-78.5M	$-67.0M
Sep 2022	$28.1M	$-82.6M	$-69.7M
Dec 2022	$29.3M	$-86.7M	$-65.8M
Mar 2023	$30.9M	$-97.4M	$-86.3M
Jun 2023	$32.2M	$-104.0M	$-85.6M
Sep 2023	$37.1M	$-92.6M	$150.7M
Dec 2023	$45.1M	$-94.2M	$-90.2M
Mar 2024	$41.4M	$-139.2M	$-136.1M
Jun 2024	$54.1M	$-67.7M	$-70.4M
Sep 2024	$62.9M	$-56.1M	$-54.8M
Mar 2025	$81.7M	$-42.7M	$-41.2M
Jun 2025	$114.4M	$-12.7M	$-12.8M
Sep 2025	$164.9M	$24.9M	$25.7M
Mar 2026	$127.2M	$-36.9M	$-37.1M
Jun 2026	$169.6M	$4.0M	$-34.8M